140711000001103: Semi-Daonil 2.5mg tablets (Aventis Pharma) (product)

• SNOMED CT Concept\Pharmaceutical / biologic product\...
• \UK product\Actual medicinal product\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \UK product\Virtual medicinal product\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \UK product\Virtual therapeutic moiety\Glibenclamide\Product containing only glibenclamide in oral dose form (medicinal product form)\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \UK product\Virtual therapeutic moiety\Glibenclamide\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \UK product\Trade family\Semi-Daonil\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing urea and/or urea derivative (product)\Product containing sulfonylurea\Product containing glibenclamide\Glibenclamide\Product containing only glibenclamide in oral dose form (medicinal product form)\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing urea and/or urea derivative (product)\Product containing sulfonylurea\Product containing glibenclamide\Glibenclamide\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing urea and/or urea derivative (product)\Product containing sulfonylurea\Product containing glibenclamide\Product containing glibenclamide in oral dose form (medicinal product form)\Product containing only glibenclamide in oral dose form (medicinal product form)\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing sulfonamide\Product containing sulfonylurea\Product containing glibenclamide\Glibenclamide\Product containing only glibenclamide in oral dose form (medicinal product form)\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing sulfonamide\Product containing sulfonylurea\Product containing glibenclamide\Glibenclamide\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing sulfonamide\Product containing sulfonylurea\Product containing glibenclamide\Product containing glibenclamide in oral dose form (medicinal product form)\Product containing only glibenclamide in oral dose form (medicinal product form)\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide\Product containing sulfonylurea\Product containing glibenclamide\Glibenclamide\Product containing only glibenclamide in oral dose form (medicinal product form)\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide\Product containing sulfonylurea\Product containing glibenclamide\Glibenclamide\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing sulfonamide\Product containing sulfonylurea\Product containing glibenclamide\Product containing glibenclamide in oral dose form (medicinal product form)\Product containing only glibenclamide in oral dose form (medicinal product form)\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)
• \Medicinal product\Product manufactured as oral dose form\Product containing glibenclamide in oral dose form (medicinal product form)\Product containing only glibenclamide in oral dose form (medicinal product form)\Product containing precisely glibenclamide 2.5 milligram/1 each conventional release oral tablet\Semi-Daonil 2.5mg tablets (Aventis Pharma)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
17181501000001112	Semi-Daonil 2.5mg tablets (Aventis Pharma) (product)	en	Fully specified name	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module
65934701000001119	Semi-Daonil 2.5mg tablets (Sanofi)	en	Synonym	Active	Only initial character case insensitive	SNOMED CT United Kingdom drug extension module

Expanded Value Set

This concept is not in any reference sets

Back to Start